Nitric oxide (NO) inhibitors reduce the threshold for anaesthesia. We have investigated the action of anaesthetic agents on human nitric oxide synthase (NOS) activity. Thiopentone reduced mean NOS activity to 36.6 (SD 8.9) % of control at 100 mol Nitric oxide (NO) is a potent vasodilator produced from L-arginine in a variety of cells, including vascular endothelium, in response to physical and receptor stimulation, by the action of a constitutive calcium-calmodulin-dependent enzyme, nitric oxide synthase (NOS). NO is necessary for the physiological regulation of vasodilator tone, causing activation of soluble guanylate cyclase in vascular smooth muscle cells, release of cyclic GMP and thus vascular relaxation. NO has several functions in addition to its vasodilator action [1] . NOS catalyses the five-electron reduction of L-arginine to citrulline and NO, and demonstrates significant amino acid sequence homology to NADPH-cytochrome P450 reductase [2] .
Nitric oxide (NO) is a potent vasodilator produced from L-arginine in a variety of cells, including vascular endothelium, in response to physical and receptor stimulation, by the action of a constitutive calcium-calmodulin-dependent enzyme, nitric oxide synthase (NOS). NO is necessary for the physiological regulation of vasodilator tone, causing activation of soluble guanylate cyclase in vascular smooth muscle cells, release of cyclic GMP and thus vascular relaxation. NO has several functions in addition to its vasodilator action [1] . NOS catalyses the five-electron reduction of L-arginine to citrulline and NO, and demonstrates significant amino acid sequence homology to NADPH-cytochrome P450 reductase [2] .
Enflurane, isoflurane and halothane have been shown to decrease receptor generated NO-induced vascular relaxation [3] [4] [5] [6] [7] [8] but not that induced by exogenous NO-generating agents such as sodium nitroprusside [3, 5, 6] , although the exact mechanisms remain unclear. There are no reports of the influence of either volatile or i.v. anaesthetic agents on the activity of human NOS. We have shown previously NOS activity in human polymorphonuclear leucocytes (PMN) [9] and have used this ex vivo model to investigate the action of anaesthetic agents on NOS activity in humans.
Methods

PREPARATION OF CELL LYSATES
Heparinized venous blood was obtained on several occasions from a single healthy volunteer for all experiments. Polymorphonuclear leucocytes (PMN) were separated using a single step commercially available density gradient, Polymorphprep (Nycomed UK, Birmingham, UK), as described previously [9] . Briefly, 10 ml of whole blood was layered onto 2 3.5 ml of Polymorphprep, centrifuged and the mononuclear cells discarded. PMN were removed, washed in RPMI 1640 medium without glutamine (ICN Biomedicals Ltd, Thame, Oxfordshire, UK) containing HEPES buffer 20 mmol litre Ϫ1 (ICN), and any contaminating erythrocytes removed by hypotonic shock. Cells were then washed twice in phosphate-buffered saline (PBS, Dulbecco's A, pH 7.3, Oxoid-Unipath Ltd, Basingstoke, Hampshire, UK) and lysed in 1 ml of double-distilled water. The lysate was sonicated for 1 min and endogenous arginine was removed by incubating with :100 mg of washed Dowex-AG50W-X8 resin (Bio-Rad Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK) for 5 min. After centrifugation at 10 000 g, the clear supernatant was stored at Ϫ70 °C for NOS assay.
NITRIC OXIDE SYNTHASE ACTIVITY ASSAY-I.V.
ANAESTHETIC AGENTS
The assay for NOS is based on the quantitative conversion of oxyhaemoglobin to methaemoglobin by NO, which can be followed spectrophotometrically as a decrease in absorbance at 413 nm ( fig.  1 ). The activity of NOS can be calculated from the reaction rate using the molar extinction coefficient for methaemoglobin, which we have found previously to be 37.2 (mmol litre) Ϫ1 cm Ϫ1 [9] . The technique used in the present study is the same as that described previously [9] with some modifications. An incubation mixture containing superoxide dismutase 100 u. ml Ϫ1 (from bovine erythrocytes, Sigma-Aldrich Ltd, Poole, Dorset, UK), catalase 2000 u. ml Ϫ1 (from bovine liver, Sigma) and human oxyhaemoglobin 1.29 mol litre Ϫ1 , prepared as described previously [9] in PBS, was pre-warmed to 37 °C. Into 1-cm cuvettes were placed 0.5 ml of the incubation mixture, 0.2 ml of cell lysate and 0. . The cuvettes were then placed in a spectrophotometer (Lambda 2, with PECSS software package, Perkin Elmer, Beaconsfield, Bucks, UK) maintained at 37 °C, and the reaction was initiated by the addition of 0.1 ml of ␤ NADPH 2 mol litre Ϫ1 (Sigma) and 0.1 ml of L-arginine 0.3 mol litre Ϫ1 (Sigma). Absorbance was recorded at 413 nm for 3 min and the slope found, to give a reaction rate (change in absorbance units per minute).
NITRIC OXIDE SYNTHASE ACTIVITY ASSAY -HALOTHANE
After washing in PBS, isolated cells were resuspended in PBS and 0.2-ml aliquots placed in small uncapped conical tubes. These were then positioned inside a 30-ml capacity gas-tight glass vessel, into which had been pipetted a volume of halothane (Fluothane, ICI Pharmaceuticals, Macclesfield, Cheshire, UK), calculated to give final concentrations of 0, 1, 2, 3 or 4 % in air. The vessels were capped and allowed to equilibrate. Cells were exposed to halothane for 30 min and then centrifuged, lysed and sonicated as previously. For the NOS assay, cell lysates were treated as described above, except that 0.1 ml of PBS was added instead of the i.v. anaesthetic agents.
The direct effect of the anaesthetic agents on the assay system was also investigated in the absence of NOS.
SUPEROXIDE DISMUTASE ASSAY
The effect of anaesthetic agents on superoxide dismutase (SOD) activity was investigated using a commercially available spectrophotometric kit (R&D Systems Europe, Oxford, UK). The activity of bovine SOD 500 u. ml Ϫ1 was measured in the presence of etomidate, thiopentone and ketamine at final concentrations of 100 mol litre Ϫ1 , 1 mmol litre Ϫ1 and 10 mmol litre
Ϫ1
, and compared with activity without the test agents. Bovine SOD was exposed also to 0-4 % halothane before assay, as described for NOS. In addition we investigated the direct effect of the anaesthetics on the assay system in the absence of SOD.
L-ARGININE MEASUREMENT
The effect of the anaesthetic agents on the stability of L-arginine was assessed by high performance liquid chromatography (HPLC) [10] . L-Arginine 30 mmol litre Ϫ1 in PBS was incubated with 100 l of etomidate, thiopentone or ketamine 10 mmol litre Results are expressed as mean (SD) percentages of the activity in the absence of anaesthetic, and represent five replicate experiments. Synthase activity in cell lysates after exposure to each concentration of anaesthetic agent was compared with activity in the absence of anaesthetic by Student's paired t test, using the raw data, that is before conversion to percentage activity for presentation purposes. Differences were taken to be significant when P : 0.05.
Results
NITRIC OXIDE SYNTHASE
NOS activity isolated from PMN was reduced in the presence of all anaesthetic agents tested. Thiopentone reduced the activity to 36.6 (8.9) % of control activity at 100 mol litre Ϫ1 (P Ͻ 0.001) and 50.9 (20.3) % at 1 mmol litre Ϫ1 (P Ͻ 0.05, fig. 2A ). Ketamine showed a similar effect, with activity reduced to 67.0 (17.6) % (P Ͻ 0.05) and 57.7 (8.5) % (P Ͻ 0.001) at 100 mol litre Ϫ1 and 1 mmol litre Ϫ1 , respectively ( fig. 2B ). With etomidate 100 mol litre
Ϫ1
, the activity of NOS was not significantly . 2C ), Halothane also caused a significant decrease in NOS activity at all concentrations ( fig. 3) . The anaesthetic agents alone had no effect on the assay system for NOS.
SUPEROXIDE DISMUTASE
None of the anaesthetic agents had any effect on SOD activity at any concentration studied, and no agent interfered with the measurement of SOD by the assay used.
L-ARGININE
We were unable to show any reduction in concentration when arginine was exposed to anaesthetic agents.
Discussion
We have demonstrated a profound effect of both volatile and i.v. anaesthetic agents on NOS activity from isolated human PMN. Previous animal studies have demonstrated inhibition of receptor generated NO-dependent relaxation of aortic rings by volatile anaesthetic agents [3] [4] [5] [6] [7] [8] . Many explanations have been suggested, including interaction with cyclic GMP phosphodiesterase enzymes [4] , modification of the half-life of NO [8] , interference with the release of NO [3] or stimulation of the release of a constricting factor [7] .
The inhalation anaesthetics, halothane and isofluorane, have been shown to reduce rat brain NOS activity, but in contrast with the present study, these workers found no effect of pentobarbitone, ketamine, fentanyl or midazolam [11] . Variation in NOS from different cell types is apparent [12] . Cytosolic NOS isolated from rat PMN is calcium-dependent, but calmodulin-independent [13] , while that from rat brain is dependent on both calcium and calmodulin [14] . The isoform induced by endotoxin-cytokine exposure in murine macrophages is dependent on neither [12] . In rat PMN, 70 % of the enzyme activity is cytosolic, and 30 % is particulate, with markedly different specific activities, whereas that from rat brain is entirely soluble [13] . There have been no similar studies in human cell types, and it is not known if significant species variation occurs. This is the first study of the effect of anaesthetic agents on NOS activity in human cells.
SOD was included in the assay for NOS in the present study to remove any superoxide, as the presence of superoxide would reduce apparent NOS activity by reacting preferentially with NO [9, 15] . The effect of the anaesthetic agents on the activity of SOD was investigated therefore in order to preclude inadequate removal of superoxide as an explanation for apparent reductions in NOS activity. The anaesthetic agents used did not have any effect on SOD activity or any inhibitory effect on the assays used to measure either SOD or NOS.
The mechanisms of the inhibitory action of the anaesthetics on NOS activity are speculative. The effect of i.v. and volatile anaesthetics on NOS may work via different mechanisms. In the present study, whole cells were exposed to halothane, rather than cell lysates as for thiopentone, etomidate and ketamine. Halothane has been shown to inactivate NADPH-cytochrome P450 reductase, an enzyme which has significant amino acid sequence homology to NOS [2] . Our studies of the lack of effect of anaesthetics on SOD, and other enzyme studies [16] , show that this enzyme inhibition is clearly not a nonspecific phenomenon. It is possible that the anaesthetic agents or their metabolites may interfere in some way with the availability of L-arginine. However, investigation of the interaction of ketamine, etomidate and thiopentone with L-arginine using HPLC failed to find any evidence to support this explanation.
It has been shown in animal studies that the anaesthetic effect of both i.v. and volatile anaesthetic agents is augmented by NO inhibitors, such that the threshold for anaesthesia is reduced [17, 18] . NO is thought to function as a neurotransmitter involved in excitory amino acid-mediated neurotoxicity, consciousness, learning and memory [19] . Cellular influxes of calcium are promoted by increased concentrations of excitatory amino acids, through activation of N-methyl-D-aspartate (NMDA) receptors. In rats, antagonists of NMDA receptors reduce the minimal alveolar concentration for isofluorane [20] and NO inhibitors block spinal sensitization mediated by NMDA receptors [21] . Ketamine in particular is a known NMDA antagonist, and pentobarbitone enhances GABAmediated inhibitory neurotransmission, thus indirectly increasing excitatory amino acid neurotransmission. Data from these studies and the present study strongly suggest that NO plays a role in the molecular mechanism of anaesthesia in humans, possibly via interaction with NMDA receptors, in both i.v. and inhalation anaesthesia.
